Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-05-28

Clinical Trial Update: rhBMP-2 vs Autologous Bone Grafting for the Treatment of Non-union of the Docking Site in Tibial Bone Transport [NA]

View source ↗

Summary

This clinical trial update compares recombinant human bone morphogenetic protein-2 (rhBMP-2) to autologous bone grafting for treating pseudarthrosis at the dock…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • bone morphogenetic protein-2 (recombinant human bone morphogenetic protein-2)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Pseudarthrosis | NA | Status: UNKNOWN